CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis

Clinical Genetics

Volumn 76, Issue 3, 2009, Pages 282-286

  Chiang, H S ^a,d   Lu, J F ^a   Liu, C H ^b   Wu, Y N ^a   Wu, C C ^b,c  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

Congenital bilateral absence of the vas deferens; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Male infertility; Sweat chloride

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CONGENITAL BILATERAL ABSENCE OF THE VAS DEFERENS; CONTROLLED STUDY; CYSTIC FIBROSIS; DINUCLEOTIDE REPEAT; GEL ELECTROPHORESIS; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MUTATIONAL ANALYSIS; POPULATION GENETICS; PRIORITY JOURNAL; SEMINAL VESICLE; SEQUENCE ANALYSIS; TAIWAN; UROGENITAL TRACT MALFORMATION;

ADULT; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE FREQUENCY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPETITIVE SEQUENCES, NUCLEIC ACID; TAIWAN; VAS DEFERENS;

EID: 70350143207     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2009.01258.x     Document Type: Article

References (30)

1. Chillón M, Casals T, Mercier B. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995, 332:1475-1480.
2. Casals T, Bassas L, Egozcue S. Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum Reprod 2000, 15:1476-1483.
3. Schlegel PN, Shin D, Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol 1996, 155:1644-1648.
4. de la Taille A, Rigot JM, Mahe P. Correlation between genito-urinary anomalies, semen analysis and CFTR genotype in patients with congenital bilateral absence of the vas deferens. Br J Urol 1998, 81:614-619.
5. Imaizumi Y. Incidence and mortality rates of cystic fibrosis in Japan, 1969-1992. Am J Med Genet 1995, 58:161-168.
6. Alper T, Shu SG, Lee MH. Detection of novel CFTR mutations in Taiwanese cystic fibrosis patients. J Formos Med Assoc 2003, 102:287-291.
7. Wu CC, Hsieh-Li HM, Lin YM. Cystic fibrosis transmembrane conductance regulator gene screening and clinical correlation in Taiwanese males with congenital bilateral absence of vas deferens. Hum Reprod 2004, 19:250-253.
8. Wu CC, Alper T, Lu JF. Mutation spectrum of the CFTR gene in Taiwanese patients with congenital bilateral absence of the vas deferens. Hum Reprod 2005, 20:2470-2475.
9. Groman JD, Hefferon TW, Casals T. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet 2004, 74:176-179.
10. Chen TJ, Boles RG, Wong LJ. Detection of mitochondrial DNA mutations by temporal temperature gradient gel electrophoresis. Clin Chem 1999, 45:1162-1167.
11. Wong LJ, Wang J, Zhang YH. Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat 2001, 18:296-307.
12. Wong L-JC, Alper T. Detection of CFTR mutations using temporal temperature gradient gel electrophoresis. Electrophoresis 2004, 25:2593-2601.
13. Kuligowska E, Baker CE, Oates RD. Male infertility: role of transrectal US in diagnosis and management. Radiology 1992, 185:353-360.
14. Barben J, Ammann RA, Metlagel A. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis. J Pediatr 2005, 146:183-188.
15. Kiesewetter S, Macek M, Davis C. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993, 5:274-278.
16. Anzai C, Morokawa N, Okada H. CFTR gene mutations in Japanese individuals with congenital bilateral absence of the vas deferens. J Cyst Fibros 2003, 2:14-18.
17. Kimura S, Okabayashi Y, Inushima K. Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis. Dig Dis Sci 2000, 45:2007-2012.
18. Chang MC, Chang YT, Wei SC. Spectrum of mutations and variants/haplotypes of CFTR and genotype-phenotype correlation in idiopathic chronic pancreatitis and controls in Chinese by complete analysis. Clin Genet 2007, 71:530-539.
19. Stuhrmann M, Dörk T. CFTR gene mutations and male infertility. Andrologia 2000, 32:71-83.
20. Mishra A, Greaves R, Massie J. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev 2005, 26:135-151.
21. Gaillard DA, Carré-Pigeon F, Lallemand A. Normal vas deferens in fetuses with cystic fibrosis. J Urol 1997, 158:1549-1552.
22. Lee CH, Wu CC, Wu YN. Gene copy number variations in Asian patients with congenital bilateral absence of the vas deferens. Hum Reprod 2009, 24:748-755.
23. Chiang HS, Wu CC, Wu YN. CFTR mutation analysis of a Caucasian father with congenital bilateral absence of vas deferens, a Taiwanese mother, and twins resulting from ICSI procedure. J Formos Med Assoc 2008, 107:736-740.
24. Cottin V, Thibout Y, Bey-Omar F. Late CF caused by homozygous IVS8-5T CFTR polymorphism. Thorax 2005, 60:974-975.
25. Dörk T, Dworniczak B, Aulehla-Scholz C. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet 1997, 100:365-377.
26. Claustres M, Guittard C, Bozon D. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat 2000, 16:143-156.
27. Jarvi K, McCallum S, Zielenski J. Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations. Fertil Steril 1998, 70:724-728.
28. Grangeia A, Niel F, Carvalho F. Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens. Hum Reprod 2004, 19:2502-2508.
29. Lissens W, Mahmoud KZ, El-Gindi E. Molecular analysis of the cystic fibrosis gene reveals a high frequency of the intron 8 splice variant 5T in Egyptian males with congenital bilateral absence of the vas deferens. Mol Hum Reprod 1999, 5:10-13.
30. Radpour R, Gourabi H, Gilani MA. Molecular study of (TG)m(T)n polymorphisms in Iranian males with congenital bilateral absence of the vas deferens. J Androl 2007, 28:541-547.